Fred Alger Management, LLC Global Blood Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $365,600 - $654,880	-8,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $748,275 - $955,515	-16,500 Reduced 67.35%	8,000 $388,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $131,500 - $158,225	2,500 Added 11.36%	24,500 $1.29 Million
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $39,990 - $53,480	-1,000 Reduced 4.35%	22,000 $1.16 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $31,540 - $46,670	1,000 Added 4.55%	23,000 $944,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $371,944 - $500,166	-9,788 Reduced 30.79%	22,000 $836,000
Q2 2018 Jul 19, 2018	BUY	$38.7 - $50.15 $920,595 - $1.19 Million	23,788 Added 297.35%	31,788 $1.44 Million
Q1 2018 May 10, 2018	BUY	$39.6 - $65.9 $316,800 - $527,200	8,000 New	8,000 $386,000
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $89,100 - $137,100	-3,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $75,300 - $93,150	3,000	3,000 $93,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.